Video-Based Intervention in Reducing Anxiety in Patients Undergoing Lung Cancer Screening
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Lung Cancer |
| Therapuetic Areas: | Oncology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 55 - Any |
| Updated: | 9/12/2018 |
| Start Date: | December 8, 2014 |
| End Date: | September 6, 2018 |
Pilot Study of a Video-Based Intervention to Reduce Psychological Harm Associated With Lung Cancer Screening
This pilot trial studies a video-based intervention in reducing anxiety in patients
undergoing lung cancer screening. Giving a video-based intervention to patients prior to lung
cancer screening may reduce anxiety and improve the well-being and quality of life.
undergoing lung cancer screening. Giving a video-based intervention to patients prior to lung
cancer screening may reduce anxiety and improve the well-being and quality of life.
PRIMARY OBJECTIVES:
I. Test the feasibility and acceptability of the video-based intervention.
SECONDARY OBJECTIVES:
I. To describe incidence, degree, and duration of screen-related anxiety among individuals
scheduled to undergo low-dose computed tomography (CT) scan (LDCT) for lung cancer screening
(LCS).
II. To describe baseline patient characteristics and pre-screening anxiety levels.
III. To describe the preliminary outcomes on screen-related anxiety for patients both not in
the intervention group and those in the intervention group.
OUTLINE: Patients are assigned to 1 of 2 groups.
GROUP I: Patients receive standard of care following LCS consisting of routine visits and
telephone contact with the LCS program nurse practitioner and coordinator.
GROUP II: Patients undergo a video-based intervention prior to undergoing LCS. Patients watch
a 5-minute video that focuses on preparing patients for LCS by providing information on the
following: program team and contact information; reason to be screened; screening
eligibility; how screening is performed; what to expect on the day of screening; what to
expect after screening; what to expect if result is positive; what to expect if result is
negative; and risks of screening. Patients also receive an educational handbook. Patients
with positive scans (a Lung-Imaging Reporting and Data Systems [RADS] 3 or 4) receive
additional brochure and nursing support within 1 week after notification of scan results.
After completion of LCS, patients are followed up at 1 week and then at 3 and 7 months.
I. Test the feasibility and acceptability of the video-based intervention.
SECONDARY OBJECTIVES:
I. To describe incidence, degree, and duration of screen-related anxiety among individuals
scheduled to undergo low-dose computed tomography (CT) scan (LDCT) for lung cancer screening
(LCS).
II. To describe baseline patient characteristics and pre-screening anxiety levels.
III. To describe the preliminary outcomes on screen-related anxiety for patients both not in
the intervention group and those in the intervention group.
OUTLINE: Patients are assigned to 1 of 2 groups.
GROUP I: Patients receive standard of care following LCS consisting of routine visits and
telephone contact with the LCS program nurse practitioner and coordinator.
GROUP II: Patients undergo a video-based intervention prior to undergoing LCS. Patients watch
a 5-minute video that focuses on preparing patients for LCS by providing information on the
following: program team and contact information; reason to be screened; screening
eligibility; how screening is performed; what to expect on the day of screening; what to
expect after screening; what to expect if result is positive; what to expect if result is
negative; and risks of screening. Patients also receive an educational handbook. Patients
with positive scans (a Lung-Imaging Reporting and Data Systems [RADS] 3 or 4) receive
additional brochure and nursing support within 1 week after notification of scan results.
After completion of LCS, patients are followed up at 1 week and then at 3 and 7 months.
Inclusion Criteria:
- This study will be conducted in people scheduled to undergo baseline LDCT as part of
the City of Hope (COH) LCS program
- There are no restrictions related to performance status and life expectancy
- All subjects must have the ability to understand and the willingness to participate in
the informed consent process, although a waiver of written informed consent is
obtained for this study
Exclusion Criteria:
- Patients who do not speak or read, because all intervention materials, including the
video and written materials are in English
- Subjects, who in the opinion of the investigator, may not be able to comply with study
procedures
We found this trial at
1
site
Duarte, California 91010
Principal Investigator: Dan J. Raz
Phone: 800-826-4673
Click here to add this to my saved trials
